PT-141 (10 mg) — Research Overview
PT-141 (bremelanotide) is a melanocortin receptor agonist derived from Melanotan II, studied in a distinct area of melanocortin research in Canada. Unlike Melanotan II, its research focus is on sexual-response pathways.
Mechanism & Research Applications
PT-141 is investigated for activating melanocortin receptors (particularly MC4R) in the central nervous system, a pathway studied in relation to sexual-response signalling rather than pigmentation.
PT-141 represents a specialised research application within the melanocortin category, distinct from the pigmentation focus of Melanotan II.
Specifications
10 mg lyophilized powder per vial | ≥99% purity (HPLC-verified) | Batch-specific COA included
Quality & Sourcing in Canada
NuMe supplies PT-141 (10 mg) as part of its catalogue of research peptides in Canada and buy peptides in Canada. Every batch is verified to ≥99% purity by HPLC, ships domestically from within Canada (typically 1–3 business days), and includes a batch-specific Certificate of Analysis. Free shipping applies to orders over $300 CAD.
Frequently Asked Questions
What is PT-141 studied for?
PT-141 (bremelanotide) is researched for sexual-response pathways through central melanocortin receptor activation, distinct from the pigmentation focus of Melanotan II.
Is PT-141 the same as bremelanotide?
Yes — PT-141 and bremelanotide are the same melanocortin compound in research contexts.
Is PT-141 available in Canada?
Yes, shipped domestically with a batch COA verifying ≥99% purity. For research use only.
For Research Purposes Only. This product is intended exclusively for laboratory research and in-vitro testing. It is not for human or veterinary use, consumption, or any therapeutic application.
Reviews
There are no reviews yet.